200 related articles for article (PubMed ID: 11483288)
1. Pharmacological effects of an aldehyde type alpha/beta-adrenoceptor blocking agent with vasodilating properties.
Chiu CC; Lin YT; Tsai CH; Liang JC; Chiang LC; Wu JR; Chen IJ; Yeh JL
Gen Pharmacol; 2000 Jun; 34(6):391-400. PubMed ID: 11483288
[TBL] [Abstract][Full Text] [Related]
2. Vanillylamide-based propanolamine derivative displays alpha/beta-adrenoceptor blocking and vasodilating properties.
Yeh JL; Wu JR; Chiu CC; Chen YW; Lo YC; Lin YT; Cheng CJ; Chen IJ
J Cardiovasc Pharmacol; 2002 Jun; 39(6):803-13. PubMed ID: 12021574
[TBL] [Abstract][Full Text] [Related]
3. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
[TBL] [Abstract][Full Text] [Related]
4. Eugenodilol: a third-generation beta-adrenoceptor blocker, derived from eugenol, with alpha-adrenoceptor blocking and beta2-adrenoceptor agonist-associated vasorelaxant activities.
Huang YC; Wu BN; Lin YT; Chen SJ; Chiu CC; Cheng CJ; Chen IJ
J Cardiovasc Pharmacol; 1999 Jul; 34(1):10-20. PubMed ID: 10413061
[TBL] [Abstract][Full Text] [Related]
5. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
[TBL] [Abstract][Full Text] [Related]
6. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
7. Isoeugenolol: a selective beta1-adrenergic antagonist with tracheal and vascular smooth muscle relaxant properties.
Lin YT; Wu BN; Horng CF; Huang YC; Hong SJ; Lo YC; Cheng CJ; Chen IJ
Jpn J Pharmacol; 1999 Jun; 80(2):127-36. PubMed ID: 10440531
[TBL] [Abstract][Full Text] [Related]
8. Vasomolol: an ultra short-acting and vasorelaxant vanilloid type beta 1-adrenoceptor antagonist.
Lin YT; Wu BN; Wu JR; Lo YC; Chen LC; Chen IJ
J Cardiovasc Pharmacol; 1996 Jul; 28(1):149-57. PubMed ID: 8797149
[TBL] [Abstract][Full Text] [Related]
9. A highly selective beta1-adrenergic blocker with partial beta2-agonist activity derived from ferulic acid, an active component of Ligusticum wallichii Franch.
Wu BN; Huang YC; Wu HM; Hong SJ; Chiang LC; Chen IJ
J Cardiovasc Pharmacol; 1998 May; 31(5):750-7. PubMed ID: 9593075
[TBL] [Abstract][Full Text] [Related]
10. Capsinolol: the first beta-adrenoceptor blocker with an associated calcitonin gene-related peptide releasing activity in the heart.
Chen IJ; Yeh JL; Lo YC; Sheu SH; Lin YT
Br J Pharmacol; 1996 Sep; 119(1):7-14. PubMed ID: 8872350
[TBL] [Abstract][Full Text] [Related]
11. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
12. Vaninolol: a new selective beta 1-adrenoceptor antagonist derived from vanillin.
Wu BN; Hwang TL; Liao CF; Chen IJ
Biochem Pharmacol; 1994 Jul; 48(1):101-9. PubMed ID: 8043010
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
14. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
Miyagishi A; Nakahara H; Hara Y
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
[TBL] [Abstract][Full Text] [Related]
15. Lipid solubility of vasodilatory vanilloid-type beta-blockers on the functional and binding activities of beta-adrenoceptor subtypes.
Wu BN; Shen KP; Lin RJ; Huang YC; Chiang LC; Lo YC; Lin CY; Chen IJ
Gen Pharmacol; 2000 May; 34(5):321-8. PubMed ID: 11368887
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
17. Xanthonolol: a calcium channel and beta-adrenoceptor blocker with vasodilating properties.
Chen IJ; Liou SJ; Liou SS; Lin CN
Gen Pharmacol; 1993 Nov; 24(6):1425-33. PubMed ID: 7906662
[TBL] [Abstract][Full Text] [Related]
18. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
Maekawa H
Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
[TBL] [Abstract][Full Text] [Related]
19. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Brahmadevara N; Shaw AM; MacDonald A
Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
